Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: DNA Damage and CDH1[original query] |
|---|
| A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. Breast cancer research and treatment 2013 Nov 142 (2): 389-98. Vinayak Shaveta, Schwartz Erich J, Jensen Kristin, Lipson Jafi, Alli Elizabeth, McPherson Lisa, Fernandez Adrian M, Sharma Vandana B, Staton Ashley, Mills Meredith A, Schackmann Elizabeth A, Telli Melinda L, Kardashian Ani, Ford James M, Kurian Allison |
| Comprehensive molecular biomarker identification in breast cancer brain metastases. Journal of translational medicine 2017 12 15 (1): 269. Schulten Hans-Juergen, Bangash Mohammed, Karim Sajjad, Dallol Ashraf, Hussein Deema, Merdad Adnan, Al-Thoubaity Fatma K, Al-Maghrabi Jaudah, Jamal Awatif, Al-Ghamdi Fahad, Choudhry Hani, Baeesa Saleh S, Chaudhary Adeel G, Al-Qahtani Mohammed |
| Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network. Cancer genetics 2017 10 216-217 111-119. Slavin Thomas, Neuhausen Susan L, Rybak Christina, Solomon Ilana, Nehoray Bita, Blazer Kathleen, Niell-Swiller Mariana, Adamson Aaron W, Yuan Yate-Ching, Yang Kai, Sand Sharon, Castillo Danielle, Herzog Josef, Wu Xiwei, Tao Shu, Chavez Tanya, Woo Yanghee, Chao Joseph, Mora Pamela, Horcasitas Darling, Weitzel Jeffr |
| Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria. BMC cancer 2018 Sep 18 (1): 926. Hoyer Juliane, Vasileiou Georgia, Uebe Steffen, Wunderle Marius, Kraus Cornelia, Fasching Peter A, Thiel Christian T, Hartmann Arndt, Beckmann Matthias W, Lux Michael P, Reis And |
| Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. Journal of translational medicine 2019 6 17 (1): 189. Cai Hui, Jing Changqing, Chang Xusheng, Ding Dan, Han Ting, Yang Junchi, Lu Zhengmao, Hu Xuguang, Liu Zhaorui, Wang Jinshen, Shang Liang, Wu Shouxin, Meng Peng, Lin Ling, Zhao Jiangman, Nie Mingming, Yin K |
| Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. Frontiers in oncology 2020 9 10 1475. Khoury Katia, Tan Antoinette R, Elliott Andrew, Xiu Joanne, Gatalica Zoran, Heeke Arielle L, Isaacs Claudine, Pohlmann Paula R, Schwartzberg Lee S, Simon Michael, Korn W Michael, Swain Sandra M, Lynce Fili |
| Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing. Oncology 2020 Jun 1-6. Zhou Jing, Zhao Zhengyi, Zhang Yuzi, Bao Celimuge, Cui Longgang, Cai Shangli, Bai Yuezong, Shen Lin, Zhang Xiaoti |
| Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma. British journal of cancer 2021 1 124 (7): 1214-1221. Teo Min Yuen, Al-Ahmadie Hikmat, Seier Kenneth, Tully Christopher, Regazzi Ashley M, Pietzak Eugene, Solit David B, Tickoo Satish, Reuter Victor, Cha Eugene K, Herr Harry, Donahue Timothy, Donat Sherri M, Dalbagni Guido, Bochner Bernard H, Funt Samuel, Iyer Gopakumar V, Bajorin Dean F, Ostrovnaya Irina, Rosenberg Jonathan |
| High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers. Journal of clinical medicine 2022 3 11 (6): . Voutsadakis Ioannis |
| Prevalence and Spectrum of Predisposition Genes With Germline Mutations Among Chinese Patients With Bowel Cancer. Frontiers in genetics 2022 2 12 755629. Xie Zhengyong, Ke Yongli, Chen Junyong, Li Zehang, Wang Changzheng, Chen Yuhong, Ding Hongliang, Cheng Liya |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: